Trial Profile
Adherence of ranibizumab in patients with exudative age-related macular degeneration: A five-year follow-up retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 08 Jul 2016 New trial record